Budget misses out on tackling the NHS
Budget Day and UK Chancellor George Osborne has come under fire for largely omitting the NHS.
Read MoreAuthor: Katrina Megget
Patient centricity is achievable, says e-patient
Pharma companies are trying to be patient centric but it’s not their fault they can’t fully achieve it, a US-based e-patient and research advocate has told PharmaTimes Digital.
Read MoreDementia research gets a $100 million boost
The UK Government is spearheading a $100 million Dementia Discovery Fund in collaboration with Alzheimer’s Research UK and a number of major pharmaceutical companies.
Read MoreSandoz pays $12.6 million to settle false drug pricing allegations
Novartis’ generics unit Sandoz will be forking out $12.64 million to settle allegations it misrepresented drug pricing data to the US Medicare programme – the largest ever such settlement.
Read MoreValeant counterbids for Salix
It’s all change again in the fight for Salix Pharmaceuticals – last week’s $11 billion bid by Endo International has been binned in favour of rival bidder Valeant Pharmaceuticals International, which has put forward a revised $173-a-share offer.
Read More- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
